[SINGAPORE] Antiviral drug remdesivir can now be used to treat seriously ill Covid-19 patients in Singapore, making the country one of the first to get the nod for using the drug to treat the virus. Read more at The Business Times.
[SINGAPORE] Antiviral drug remdesivir can now be used to treat seriously ill Covid-19 patients in Singapore, making the country one of the first to get the nod for using the drug to treat the virus.To continue reading.
[SINGAPORE] Antiviral drug remdesivir can now be used to treat seriously ill Covid-19 patients in Singapore, making the country one of the first to get the nod for using the drug to treat the virus.To continue readingUnited States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Remdesivir approved for Covid-19 treatment in SingaporeInfectious diseases specialists can now administer the drug to seriously ill Covid-19 patients.. Read more at straitstimes.com.
Read more »
451 new Covid-19 cases in Singapore, including 7 community casesSINGAPORE — Singapore has confirmed 451 new cases of Covid-19 on Wednesday (June 10), said the Ministry of Health (MOH) in a statement.
Read more »
7 community cases amongst 451 new COVID-19 infections in Singapore; total close to 39,000The Ministry of Health (MOH) reported a preliminary 451 new COVID-19 cases in Singapore as of Wednesday (10 June) noon, bringing the total to 38,965.
Read more »
Singapore company to start clinical safety trials in humans for potential COVID-19 treatmentSINGAPORE: A Singapore-based company will start human clinical trials next week for a treatment that could slow down the progression of COVID-19 ...
Read more »
Singapore reports 451 new COVID-19 infections, 7 cases in the communitySINGAPORE: Singapore reported 451 new COVID-19 infections as of noon on Wednesday (Jun 10), including seven cases in the community. Three of the ...
Read more »
Singapore to begin first human trial for potential Covid-19 treatmentSINGAPORE — Next week, 23 healthy volunteers here will be involved in a clinical safety trial for an antibody drug that is hoped to be a viable treatment for patients with Covid-19, a disease that has killed more than 400,000 around the globe so far.
Read more »